Smart Inhalers Market, By Product ((Inhalers (Metered Dosage Inhalers (MDIs) and Dry Powder Inhalers (DPIs) and Nebulizers), By Distribution Channel (Hospitals and Pharmacies), and By Geography (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)

Published In : May 2023

Code : CMI5738

Pages :169

Formats :

Excel and PDF

Industry : Medical Devices

Leading Companies

Global Smart Inhalers Market: Key Developments

In January 2023, Aseptika won an Innovate UK Smart Award to develop a Smart Inhaler Tracker for patients with lung health conditions. The Smart Award will help the company develop its third-generation smart inhaler tracker, which will have 5G mobile connectivity built-in.

In February 2022 Astrazeneca and Honeywell partnered to develop next-generation respiratory inhalers using the propellant HFO-1234ze, which has up to 99.9% less global warming potential than propellants currently used in respiratory medicines.

In February 2022, Aptar Pharma announced the launch of Hero Tracker Sense, a digital respiratory health solution that transforms a standard metered dose inhaler (pMDI) into a smart connected healthcare device. Hero Tracker Sense is designed to help improve the lives of patients around the world suffering from chronic respiratory diseases to track their MDI usage and facilitate improved adherence to their prescribed therapy.

Global Smart Inhalers Market: Key Companies Insights

The global smart inhalers market is highly competitive. This is attributed to the rise in demand for smart inhalers around the world, as a result, players in the market are focusing on developing and launching novel products in the market.

Some of the key players in the global smart inhalers market are Adherium Limited, AstraZeneca, Boehringer Ingelheim, Cohero Health, GSK, Novartis, and ResMed, among others.